logo conference-reports

Conference Reports

При финансовой поддержке logo MSD Oncology

ESMO 2018 – Can advances in metastatic NSCLC be transferred to early-stage disease?

Early-stage NSCLC patients may benefit from immunotherapy and combination approaches